• 97
  • 25
  • Favorite

Global pharma shares sink as Biden backs COVID-19 vaccine IP waiver

reuters2021-05-06

Shares of COVID-19 vaccine makers plungedafter U.S. President Joe Bidenbacked a proposed waiver for intellectual property rightseven as the pharmaceutical industry, analysts and experts doubted its ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment25

  • Wallstrtbets
    ·2021-05-09
    Noted.
    Reply
    Report
  • sUs
    ·2021-05-08
    Good? 
    Reply
    Report
  • Kel9670ong
    ·2021-05-07
    Better not to have too many brand of vaccine
    Reply
    Report
  • Bibop
    ·2021-05-07
    Greedy pharma company got slash. 
    Reply
    Report
  • mcwood
    ·2021-05-07
    [得意] 
    Reply
    Report
  • 小股神来也
    ·2021-05-07
    Wow
    Reply
    Report
    Fold Replies
  • IZLIN
    ·2021-05-07
    @simplydkam@Zenekz@Meow17@Sagi08time to enter? [Observation] 
    Reply
    Report
    Fold Replies
    • simplydkam
      What clue
      2021-05-08
      Reply
      Report
    • Sagi08
      No clue
      2021-05-07
      Reply
      Report
    • Meow17
      Clueless
      2021-05-07
      Reply
      Report
  • ChouTigger
    ·2021-05-07
    Interesting read
    Reply
    Report
  • SvdB
    ·2021-05-07
    Good read
    Reply
    Report
  • Jiangbox
    ·2021-05-07
    Can go in now?
    Reply
    Report
  • thamwhaikit
    ·2021-05-07
    While this has good intentions, I’m worried about the safety since not just anyone has the expertise, quality control and knowledge on producing it safely. There will be companies that values mass reach/volume over efficacy and guess who will be on the receiving end of such a batch of vaccines, it’ll be the developing countries again.
    Reply
    Report
  • yhl77
    ·2021-05-07
    Saving lives is more important
    Reply
    Report
    Fold Replies
    • AndrewL
      Right!
      2021-05-07
      Reply
      Report
  • r39
    ·2021-05-07
    It's a good move for the world but not for the vaccine companies who depends on the IP to secure their sales.
    Reply
    Report
  • SDLiuSG
    ·2021-05-07
    Right move?
    Reply
    Report
  • JBSIEW
    ·2021-05-07
    Now everyone can make a vaccine. Good or bad? U comment.
    Reply
    Report
  • 4074fdf1
    ·2021-05-07
    Goodbye upward momentum
    Reply
    Report
    Fold Replies
    • Ljoney
      Hope all the best, comment nnlike
      2021-05-08
      Reply
      Report
    • kenong62
      please like
      2021-05-07
      Reply
      Report
    • Ljoney
      Continue to Monitor, like n comment
      2021-05-07
      Reply
      Report
  • Fuzzyfuzzy
    ·2021-05-07
    Lol
    Reply
    Report
  • ORNEGU
    ·2021-05-07
    Buy when prices are low 
    Reply
    Report
  • 美國人講的都是廢話。就像我王剛給你辣子雞的配方,不給你雞,也不告訴你怎麼炒。講起來堂而皇之,實質上毛都沒有,只有傻瓜才相信。
    Reply
    Report
    Fold Replies
    • 农民人士
      坑人.简单明了
      2021-05-07
      Reply
      Report
  • Yanlaoda
    ·2021-05-06
    Hi
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial